Sign In
Buy AMRS
$0.0500
+0 (+0%)
At Close: Nov 27, 2023
BRIEF-Amyris posts Q3 GAAP loss of $1.14 per share
09:30pm, Tuesday, 14'th Nov 2017
* Amyris reports another strong quarter of product sales growth and expects strong finish for 2017
BRIEF-Amyris files for offering of up to 26.2 mln shares of common stock by selling stockholders
09:50pm, Friday, 03'rd Nov 2017
* Amyris Inc files for offering of up to 26.2 million shares of common stock by the selling stockholders - SEC filing Source text: (http://bit.ly/2zaU4Od) Further company coverage:
BRIEF-Amyris Inc enters into agreement with Koninklijke DSM N.V.
01:14pm, Thursday, 05'th Oct 2017
* Amyris enters into product development and production agreement with Royal DSM for human nutrition ingredient
BRIEF-Amyris enters into second major product development with Royal DSM
12:43pm, Tuesday, 26'th Sep 2017
* Amyris Inc enters into second major product development and production agreement with Royal DSM
BRIEF-Amyris Q2 loss per share $0.46
08:14pm, Thursday, 10'th Aug 2017
* Amyris delivers another strong quarter with revenue of $25.7 million and product sales increase of 159% over 2nd quarter of 2016
BRIEF-Vivo Capital VIII reports 9.9 pct stake in Amyris
09:06pm, Tuesday, 08'th Aug 2017
* Vivo Capital VIII LLC reports 9.9 percent passive stake in Amyris Inc as of August 2, 2017 - SEC filing Source text: (http://bit.ly/2vCkff7) Further company coverage:
BRIEF-Amyris files for offer and sale of up to 42.27 mln shares
09:44pm, Friday, 04'th Aug 2017
* Amyris Inc files for offer and sale of up to 42.27 million shares of co's common stock by the selling stockholders - sec filing Source text: (http://bit.ly/2hwaLw0) Further company coverage:
BRIEF-Amyris says second tranche of $50 mln in a private placement days is being led by a $25-mln investment from Koninklijke
01:13pm, Thursday, 03'rd Aug 2017
* Amyris announces agreements for $50 million in second tranche of equity financing, exceeding previous target of $95 million
BRIEF-Amyris enters into first product development, production agreement with Royal DSM
12:59pm, Monday, 17'th Jul 2017
* Amyris enters into first product development and production agreement with Royal DSM for food and nutrition molecule
BRIEF-Amyris, on June 30, 2017, company issued, sold an amended, restated note in principal amount of $3 mln to purchaser
09:05pm, Friday, 07'th Jul 2017
* Amyris Inc - on June 30, 2017, company issued and sold an amended and restated note in principal amount of $3.0 million to purchaser - sec filing
BRIEF-Amyris and government of Queensland announced plans to develop a industrial biotechnology hub in Southeast Asia
01:09pm, Tuesday, 20'th Jun 2017
* Amyris Inc and government of Queensland, Australia announced plans to develop a industrial biotechnology hub in Southeast Asia Source text for Eikon: Further company coverage:
BRIEF-Amyris announces reverse stock split
12:24pm, Tuesday, 06'th Jun 2017
* Amyris announces reverse stock split - delivering on strong product revenue growth and execution
BRIEF-Amyris reports Q1 loss per share of $0.13
08:40pm, Monday, 15'th May 2017
* Amyris reports 164 pct product revenue growth over prior year & continued strong outlook
Dow Jones News Today: Stocks Rise as Investors Eye Retail Earnings Reports
01:26pm, Monday, 15'th May 2017
The Dow Jones news today features stocks rising ahead of another round of retail earnings reports. Here's what's ahead for the stock market today, May 15...
